Medium materiality4/10
UBS Raises Encompass Health (EHC) Price Target to $165
Why it may matterVerify against the original reporting
Bullish analyst view, with meaningful indicated upside but no prior target or supporting rationale provided.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raised its EHC price target to $165 from an unspecified prior level; the cited price was $131.49, implying roughly 25% upside to the target. Analyst targets are opinions, not guarantees.
- UBS raised EHC’s target to $165; cited price: $131.49.
- The target is about 25% above the cited price.
Key facts
- 01
Target: $165
- 02
Posted price: $131.49
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.